These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7226711)

  • 1. Salicylate absorption from a bismuth subsalicylate preparation.
    Feldman S; Chen SL; Pickering LK; Cleary TG; Ericsson CD; Hulse M
    Clin Pharmacol Ther; 1981 Jun; 29(6):788-92. PubMed ID: 7226711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption of salicylate and bismuth from a bismuth subsalicylate--containing compound (Pepto-Bismol).
    Pickering LK; Feldman S; Ericsson CD; Cleary TG
    J Pediatr; 1981 Oct; 99(4):654-6. PubMed ID: 7277115
    [No Abstract]   [Full Text] [Related]  

  • 3. The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate).
    Nwokolo CU; Mistry P; Pounder RE
    Aliment Pharmacol Ther; 1990 Apr; 4(2):163-9. PubMed ID: 2104082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth subsalicylate: history, chemistry, and safety.
    Bierer DW
    Rev Infect Dis; 1990; 12 Suppl 1():S3-8. PubMed ID: 2406853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
    Healy DP; Dansereau RJ; Dunn AB; Clendening CE; Mounts AW; Deepe GS
    Ann Pharmacother; 1997 Dec; 31(12):1460-4. PubMed ID: 9416381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pepto-bismol and salicylate levels.
    Shanbrom E
    Mayo Clin Proc; 1989 Jan; 64(1):129. PubMed ID: 2911212
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of subsalicylate bismuth on absorption of doxycycline.
    Ericsson CD; Feldman S; Pickering LK; Cleary TG
    JAMA; 1982 Apr; 247(16):2266-7. PubMed ID: 7040708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative absorption of bismuth in Sprague-Dawley rats following oral administration of preparations containing bismuth sucrose octasulfate, bismuth subsalicylate, and bismuth subcitrate.
    Rao N; Brown PW; Yerino P; Chang J; Hwang KK
    Biopharm Drug Dispos; 1997 Jan; 18(1):1-8. PubMed ID: 9008264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds.
    Nwokolo CU; Prewett EJ; Sawyerr AM; Hudson M; Pounder RE
    Gastroenterology; 1991 Oct; 101(4):889-94. PubMed ID: 1889712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of bismuth subsalicylate and intracellular accumulation of bismuth by Fusarium sp. strain BI.
    Dodge AG; Wackett LP
    Appl Environ Microbiol; 2005 Feb; 71(2):876-82. PubMed ID: 15691943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
    Rambout L; Sahai J; Gallicano K; Oliveras L; Garber G
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2187-90. PubMed ID: 7811043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylate toxicity from chronic bismuth subsalicylate use.
    Halani S; Wu PE
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site of bismuth absorption from bismuth subsalicylate: implications for treatment of colonic conditions.
    Suarez FL; Furne J; Stiehm J; Garten C; Levitt MD
    Dig Dis Sci; 2000 Jul; 45(7):1444-6. PubMed ID: 10961727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.
    Froomes PR; Wan AT; Keech AC; McNeil JJ; McLean AJ
    Eur J Clin Pharmacol; 1989; 37(5):533-6. PubMed ID: 2598996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.
    Kocoshis SA; Ghent CN; Gryboski JD
    Dig Dis Sci; 1984 Dec; 29(12):1148-52. PubMed ID: 6499633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.
    Gump DW; Nadeau OW; Hendricks GM; Meyer DH
    Med Microbiol Immunol; 1992; 181(3):131-43. PubMed ID: 1522823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats.
    Yue TL; Varma DR
    Drug Metab Dispos; 1982; 10(2):147-52. PubMed ID: 6124400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bismuth Subsalicylate Coagulopathy in a Patient with Chronic Liver Disease.
    Yu C; Eustaquio N; Calello DP; Ruck BE; Nelson LS; Santos C
    J Med Toxicol; 2019 Jul; 15(3):198-201. PubMed ID: 31062178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbits.
    Tay HP; Chaparala RC; Harmon JW; Huesken J; Saini N; Hakki FZ; Schweitzer EJ
    Gut; 1990 Jan; 31(1):11-6. PubMed ID: 2108076
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.